SCOTT MARTZ: Open Payments
NPI 1861485294 · FLOWER MOUND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$914 in 46 payments from 20 companies in 2025. Trend: 2023 $1,032 · 2024 $908 · 2025 $914
Food & beverage: $914
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $139 |
| ABBVIE INC. | 6 | $107 |
| Eisai Inc. | 4 | $105 |
| Corcept Therapeutics | 3 | $103 |
| Novo Nordisk Inc | 3 | $58 |
| Lilly USA, LLC | 3 | $56 |
| Lundbeck LLC | 2 | $52 |
| GlaxoSmithKline, LLC. | 3 | $46 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $34 |
| Amgen Inc. | 2 | $32 |
Products named: Leqembi, Korlym, JARDIANCE, FARXIGA, VYEPTI, BREZTRI, UBRELVY, QULIPTA.
Industry payments across TX — which companies pay providers there.
